Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · EXAGEN INC. (XGN)

Exagen director Ana Hooker resigns from board effective April 17, 2026

Neutral Impact 2 of 5 leadership Written later

Exagen director Ana Hooker resigned from the Board, including her Audit Committee seat and chair role on the Nominating and Corporate Governance Committee, effective April 17, 2026. The filing says the resignation was not due to any disagreement with the company on its operations, policies or practices, and the board was reduced from eight to seven members.

Key points

  • Ana Hooker resigned from the Board effective April 17, 2026, the date she notified the Board.
  • Hooker was a member of the Audit Committee and chair of the Nominating and Corporate Governance Committee.
  • Board size decreased from eight to seven members as of the effective time.
  • The filing states no disagreement with the company on operations, policies or practices was the reason for the resignation.

The filing

CompanyEXAGEN INC. (XGN)
Form8-K, current report
Filed with the SECApr 23, 2026, 4:02 PM ET
Accession number0001274737-26-000015

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 23, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.